STRIVE clinical trial now available in Aotearoa New Zealand to improve outcomes in vulvar cancer Media Release - 24 February 2026 The Australian New Zealand Gynaecological Oncology Group (ANZGOG) in partnership with the Canadian Cancer Trials Group (CCTG) [...]
Blood test offers hope for more effective ovarian cancer treatment Media Release - 12 November 2025 New clinical research has identified a blood test that can reveal which women are more likely to respond to a particular treatment [...]
Meet Dr Gwo Yaw Ho - Winner of the 2025 Michael Friedlander AM Award Senior Medical Oncologist at Monash Health, Dr Gwo Yaw Ho, is the 2025 Michael Friedlander AM Award recipient, an annual award [...]
As part of ANZGOG’s #GynaeCancerMatters campaign for Gynaecological Cancer Awareness Month, we are pleased to feature an insightful interview with Associate Professor Alison Davis. Assoc Prof Alison Davis, Medical Oncologist (ACT) With over 20 years [...]
ANZGOG' EPOCH is a Phase II open label international clinical trial, which seeks to improve outcomes in women with tubo-ovarian or uterine carcinosarcoma by providing patients with access to a treatment that offers a greater degree [...]
The EN.10/TAPER study is open to recruitment in eight Australian sites and one site in New Zealand. This trial explores ways to treat early-stage endometrial cancers with a focus on minimising side effects and costs. The [...]
Immunotherapy is rapidly emerging as a promising cancer treatment. Unfortunately, endometrial cancer patients currently lack access to this innovative approach. In response to the rising cases of endometrial cancer globally, DOMENICA is addressing the need to [...]
2,200 ANZ women are diagnosed with ovarian cancer every year, and less than half will survive beyond five years. ANZGOG’s IGNITE trial is testing how effective a new treatment is for patients with relapsed high grade [...]
If you are a GP, practice nurse, oncologist, oncology nurse, menopause specialist, oncology surgeon, surgical nurse, gynaecological oncologist, or pharmacist, ANZGOG invites you to take part in this study. ANZGOG is supporting this study which [...]
The XPORT-EC-042 study is open to recruitment in Australia, after Border Medical Oncology Research Unit and Peter MacCallum Cancer Centre were activated. The trial is led by Karyopharm Therapeutics (Global Sponsor), in collaboration with ANZGOG, European [...]
Australia New Zealand Gynaecological Oncology Group www.anzgog.org.au
Level 6, Lifehouse, 119-143 Missenden Road Camperdown NSW 2050 T:+61 2 8071 4880
E: contact@anzgog.org.au © 2026 ANZGOG | Copyright | Disclaimer | ANZGOG Policies | Whistleblower
Virtually every advance in cancer survival has been made on the back of clinical trials.
As the peak, national gynaecological cancer clinical trials organisation for Australia and New Zealand, ANZGOG‘s purpose is to improve outcomes and quality of life for women with gynaecological cancer by conducting research.
We conduct and promote clinical trials and undertake multidisciplinary research into the causes, prevention and treatments of gynaecological cancers.
Research Community Volunteers will have the opportunity to contribute to ANZGOG research at every stage of the development process.
Community volunteers will lend their voices to research discussions sharing their personal perspective and representing the broader views of people with lived experience of gynaecological cancer.
Opportunities range from sharing your lived experience as a participant on a research grant working party or a Trial Management Committee, through to Research Advisor and Expert roles requiring additional levels of education and expertise in research analysis.
Gynaecological cancer research is critically needed but critically underfunded. WomenCan is the fundraising arm of ANZGOG, supporting ANZGOG by funding our programs to improve life for women with gynaecological cancer.
WomenCan’s mission is to engage the community to fund pioneering discoveries that will enable women with a gynaecological cancer to live better and live longer.
WomenCan believes the power of the collective, united in a common purpose, can make a real difference in the lives of women with gynaecological cancers.
ANZGOG’s Survivors Teaching Students (STS) Program is a ground-breaking volunteer program that brings gynaecological cancer survivors and caregivers into the classrooms of health professional students to teach them about women’s experiences with the diseases.
Survivors and caregivers are in a unique position to help students understand the ‘lived experience’ of a gynaecological cancer, including the psychosocial impact, and the importance of timely diagnosis, good health communication and compassionate care.
By joining STS and sharing your story, you will have the opportunity to impact the future care of women diagnosed with a gynaecological cancer, with participating students reporting not only increased understanding of gynaecological cancers but also a deeper understanding of the patient experience to take forward into their practice.
Since the program began at ANZGOG in 2017, our volunteers have shared their stories with more than 11,000 students across Australia and New Zealand.
